Related Experiment Videos
Caffeine clearance study in hepatocellular carcinoma
P Tangkijvanich1, S Wittayalertpanya, T Kusonsolboon
1Department of Biochemistry, Faculty of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand.
Summary
Plasma caffeine clearance effectively assesses liver function in patients with cirrhosis and hepatocellular carcinoma (HCC). Lower clearance indicates poorer liver reserve, correlating with HCC severity and potentially predicting survival outcomes.
Area of Science:
- Hepatology
- Oncology
- Pharmacokinetics
Background:
- Cirrhosis significantly impairs hepatic metabolic capacity.
- Hepatocellular carcinoma (HCC) further complicates liver function in cirrhotic patients.
- Accurate assessment of hepatic functional reserve is crucial for managing these patients.
Purpose of the Study:
- To evaluate hepatic metabolic capacity in cirrhotic patients with HCC.
- To compare plasma caffeine clearance between cirrhosis alone and cirrhosis with HCC.
- To correlate caffeine clearance with disease severity and tumor staging.
Main Methods:
- Plasma caffeine clearance was measured using two-point analysis.
- Patients were categorized into cirrhosis alone and cirrhosis with HCC groups.
- Groups were stratified by Child-Pugh score (compensated vs. decompensated) and HCC staging (Okuda criteria).
Main Results:
- Caffeine clearance was significantly higher in compensated cases than decompensated cases, especially in the HCC group (p=0.001).
- Mean caffeine clearance in HCC patients correlated with Okuda tumor staging.
- A negative correlation was observed between tumor size and caffeine clearance in compensated HCC cases (p=0.046).
Conclusions:
- Plasma caffeine clearance is a valuable tool for assessing hepatic functional reserve in cirrhotic patients with HCC.
- Caffeine clearance may serve as a prognostic marker for survival outcomes in this patient population.
- This pharmacokinetic parameter aids in understanding the metabolic impact of HCC on liver disease.